Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. (Q38597363)
Jump to navigation
Jump to search
scientific article published on 29 August 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. |
scientific article published on 29 August 2017 |
Statements
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia (English)
Cliona M Rooney
Michael Boyiadzis
Mounzer Agha
Robert L Redner
Alison Sehgal
Annie Im
Jing-Zhou Hou
Rafic Farah
Kathleen A Dorritie
Anastasios Raptis
Seah H Lim
Natalia Lapteva
Zhuyong Mei
Lisa H Butterfield
Theresa L Whiteside